Report Overview

The global pain management drugs market size stood at around USD 71 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 3.82% during the forecast period

The market is being strictly regulated by the U.S. FDA due to a substantial number of drug-abuse deaths registered in the country. The FDA has released specific guidelines to manufacture, market, store, and sell opioid products. For instance, removal of OTC cough syrup containing opioids is a result of guidelines set by the regulatory body. In addition, prescription by healthcare professionals is being highly regulated



Market Drivers

Rise in geriatric population is the major factor that drives growth of the global pain management drugs market as aged people are more prone to suffer from joint pain and other chronic conditions. Moreover, surge in prevalence of chronic diseases, such as cancer, diabetic neuropathy, and osteoarthritis propels the market growth. Furthermore, rise in number of surgical procedures and rise in healthcare expenditure are expected to fuel growth of the pain management drugs market

Major Types of Pain

The major types of pain includes arthritic pain, neuropathic pain, cancer pain, chronic pain, post-operative pain, migraine, fibromyalgia, bone fracture, muscle sprain/strain and acute appendicitis. The neuropathic pain segment accounted for a majority of the market share in 2019, and is expected to exhibit a prominent growth rate during the forecast period. In addition, increase in presence of large patient population is the major factor that increases demand for drugs for the segment. Cancer pain and chronic back pain segments are expected to grow at the highest rate throughout the forecast period, owing to increase in number of surgeries globally and rise in prevalence of chronic diseases that lead to back pain